The signing ceremony of the Fuzhou High-tech Zone Zhongene New Materials (Jiangxi) Industrial Park project was held
Time of Update: 2022-08-28
On the morning of May 28, the signing ceremony of the Fuzhou High-tech Zone Zhongene New Materials (Jiangxi) Industrial Park project was held in the conference room on the second floor of the Management Committee.
More than 240 pharmaceutical companies have disclosed performance forecasts, with dazzling net profits concentrated in the fields of vaccines and testing
Time of Update: 2022-05-02
. In addition to Zhifei Bio and CanSino, the net profit of vaccine companies such as Olin Bio and Kangtai Bio is also expected to increase significantly year-on-year in 2021.
130 million capital increase
Time of Update: 2022-04-26
Capital increase method and source of capital: The 130 million yuan capital increase subscribed by the company will be paid in 4 installments before the end of 2022 according to the needs of production and operation.
The heavy-holding stocks of the pharmaceutical fund are exposed
Time of Update: 2022-04-21
The new periodic report of Southern Pharmaceutical Innovation Stock A shows that CXO stocks account for half of the top ten heavyweight stocks, including Yaoshi Technology, Tigermed, WuXi AppTec, Asymchem, GenScript Biotechnology, and Zhaoyan New Drug .
The growth rate of the centrifuge market exceeds 23%, and the biomedical industry is a major "support force" behind
Time of Update: 2022-03-06
Some medical centrifuge manufacturers said that facing the future, the company will continue to increase investment in research and development, attach importance to innovation, continuously improve the stability and quality of domestic centrifuges, seize the opportunity of import substitution, and help the pharmaceutical and other industries to develop with higher quality .
Hangyang Krypton-Xenon Extraction Equipment Project Awarded
Time of Update: 2022-02-26
A few days ago, at the "2015 Zhejiang Machinery Industry Science and Technology Award" awarding conference held by the Zhejiang Machinery Industry Federation, the krypton-xenon extraction device project developed by Hangyang won the first prize .
The project was selected as the first set of products in the key field of Zhejiang Province’s equipment manufacturing industry in 2015.
The cell and gene therapy industry has a high boom, the industry is optimistic about the CGTCDMO track
Time of Update: 2021-12-06
With the continuous growth of the gene cell therapy market, this field is also favored by investors.
Under the influence of policies and capital, the prosperity of the cell and gene therapy industry is expected to continue, and the CGTCDMO track is also favored by the industry .
MTO (Methanol to Olefin) and its downstream industry chain green development alliance was established
Time of Update: 2021-12-06
Recently, MTO (Methanol to Olefin) and its downstream industry chain green development alliance inaugural meeting was held in Guangzhou (Luoyang) Engineering Company .
The alliance is jointly initiated by Guangzhou (Luoyang) Engineering Company, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, and Levima New Materials Technology Co.
Speed up the construction of industrial infrastructure, "data + AI" and implement intelligent transformation
Time of Update: 2021-10-25
[ Focus on Chemical Machinery Equipment Network ] As a new track of the digital economy that directly serves the industry, the Industrial Internet has been applied to 37 key industries of the nationa
Reuse of waste coatings has aroused global attention
Time of Update: 2021-07-26
Global Coatings Network News: United Kingdom According to BCF estimates, 55 million liters of residual paint are produced in the UK every year, and about 98% of them are disposed of by landfill or incineration after paying a high fee to the local government.
Takeda sells its US$670 million assets and injects US$500 million into BridGene
Time of Update: 2021-07-12
At the same time, as new technologies opened up new avenues for the development of small molecule drugs, Takeda decided to invest US$500 million in BridGene Biosciences, a drug research and development company .
The second round of guidance services in the key counties of hazardous chemicals in Shanghai Fengxian District and Hangzhou Qiantang New District started
Time of Update: 2021-07-02
Li Qiuwei, director of the Jiangbei New Area Work Safety Supervision Bureau, notified the rectification of problems found in the first round of expert guidance services.
ClinicalMind completed a recapitalisation to expand its strategic agency business
Time of Update: 2021-03-01
Jesse Serventi, founding partner of Renovus, said: "After extensive searches, we are pleased to be working with a leading medical communications company and management team that is changing the medical field as they continue to respond to the rapid development of rare diseases and the development of high-tech methods such as gene and cell therapy.
The EMA issued a new policy for the publication of clinical studies
Time of Update: 2021-02-05
same time, BadPharma author Goldacre also expressed concern about the editing process, noting that the EMA and AbbVie reached a consensus this year to "review CSR's public release of changes to the program." "The change in the scheme in the trial is precisely the information that researchers need to make informed decisions about whether the trial is a 'fair test' of the drug," he said.
Let the world be free of harmful paintings-an interview with Mr. Luo Biao, CEO of Tiger China
Time of Update: 2020-06-19
Mr Luo Biao, CEO of tiger surface technology new materials (Suzhou) Co., Ltd Institute tiger company has officially entered the Chinese market since 2000 After 20 years of d